![James J. Tufts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James J. Tufts
Amministratore Delegato presso ANTH1, Inc.
Profilo
James J.
Tufts is currently the President & Chief Executive Officer of ANTH1, Inc. He received his undergraduate degree from the University of Illinois in 1973.
Posizioni attive di James J. Tufts
Società | Posizione | Inizio |
---|---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Amministratore Delegato | 17/07/2008 |
Formazione di James J. Tufts
University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
- Borsa valori
- Insiders
- James J. Tufts